184 related articles for article (PubMed ID: 28992140)
1. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
Cafiero C; Gigante M; Brunetti G; Simone S; Chaoul N; Oranger A; Ranieri E; Colucci S; Pertosa GB; Grano M; Gesualdo L
Nephrol Dial Transplant; 2018 Jan; 33(1):65-75. PubMed ID: 28992140
[TBL] [Abstract][Full Text] [Related]
2. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.
Herrera BS; Bastos AS; Coimbra LS; Teixeira SA; Rossa C; Van Dyke TE; Muscara MN; Spolidorio LC
J Periodontol; 2014 Apr; 85(4):e72-81. PubMed ID: 24059638
[TBL] [Abstract][Full Text] [Related]
4. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.
Sabokbar A; Mahoney DJ; Hemingway F; Athanasou NA
Clin Rev Allergy Immunol; 2016 Aug; 51(1):16-26. PubMed ID: 26578261
[TBL] [Abstract][Full Text] [Related]
5. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes.
Riedlova P; Sood S; Goodyear CS; Ansalone C
J Vis Exp; 2023 Jan; (191):. PubMed ID: 36779608
[TBL] [Abstract][Full Text] [Related]
8. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.
Meednu N; Zhang H; Owen T; Sun W; Wang V; Cistrone C; Rangel-Moreno J; Xing L; Anolik JH
Arthritis Rheumatol; 2016 Apr; 68(4):805-16. PubMed ID: 26554541
[TBL] [Abstract][Full Text] [Related]
9. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL).
Nicholson GC; Malakellis M; Collier FM; Cameron PU; Holloway WR; Gough TJ; Gregorio-King C; Kirkland MA; Myers DE
Clin Sci (Lond); 2000 Aug; 99(2):133-40. PubMed ID: 10918046
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
11. Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.
Faienza MF; Brunetti G; Colucci S; Piacente L; Ciccarelli M; Giordani L; Del Vecchio GC; D'Amore M; Albanese L; Cavallo L; Grano M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2269-76. PubMed ID: 19401376
[TBL] [Abstract][Full Text] [Related]
12. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Hou Y; Long W; Ye S; Wang Z
Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
[TBL] [Abstract][Full Text] [Related]
13. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
14. Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis.
Ikić M; Jajić Z; Lazić E; Ivčević S; Grubišić F; Marušić A; Kovačić N; Grčević D
Int Orthop; 2014 Jan; 38(1):183-92. PubMed ID: 24100919
[TBL] [Abstract][Full Text] [Related]
15. Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.
Panagopoulos V; Liapis V; Zinonos I; Hay S; Leach DA; Ingman W; DeNichilo MO; Atkins GJ; Findlay DM; Zannettino ACW; Evdokiou A
Mol Cell Endocrinol; 2017 Jan; 440():8-15. PubMed ID: 27836774
[TBL] [Abstract][Full Text] [Related]
16. Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
Koek WNH; van der Eerden BCJ; Alves RDAM; van Driel M; Schreuders-Koedam M; Zillikens MC; van Leeuwen JPTM
Bone; 2017 Feb; 95():108-114. PubMed ID: 27845263
[TBL] [Abstract][Full Text] [Related]
17. Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL/OPG ratio.
Caparbo VF; Saad CGS; Moraes JC; de Brum-Fernandes AJ; Pereira RMR
Osteoporos Int; 2018 Nov; 29(11):2565-2573. PubMed ID: 30006885
[TBL] [Abstract][Full Text] [Related]
18. Human circulating monocytes can express receptor activator of nuclear factor-kappaB ligand and differentiate into functional osteoclasts without exogenous stimulation.
Seta N; Okazaki Y; Kuwana M
Immunol Cell Biol; 2008 Jul; 86(5):453-9. PubMed ID: 18301383
[TBL] [Abstract][Full Text] [Related]
19. RANKL-independent modulation of osteoclastogenesis.
Feng W; Guo J; Li M
J Oral Biosci; 2019 Mar; 61(1):16-21. PubMed ID: 30929797
[TBL] [Abstract][Full Text] [Related]
20. An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.
Abdallah D; Jourdain ML; Braux J; Guillaume C; Gangloff SC; Jacquot J; Velard F
Front Immunol; 2018; 9():632. PubMed ID: 29670619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
